Skip to main content

Clovis Oncology, Inc.

CLVSDelisted Dec 29, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001466301

Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Clovis Oncology, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CLVS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders20−2
Shares36.8K0−36.8K (−100.0%)
Value$520.2K$0−$520.2K (−100.0%)

New holders (0)

Institutions that held Clovis Oncology, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

None.

Sold out (2)

Institutions that held Clovis Oncology, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of CLVS in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Resources Management Corp16,795$518.0K
MAI Capital Management20,000$2.18K